Aims: To test the hypothesis that fragments of platelet thrombi and vascular endothelium are incorporated into the walls of small cerebral vessels in systemic lupus erythematosus (SLE). Methods: Six varied necropsy cases of central nervous system (CNS) SLE and 15 controls were studied. The controls were selected to represent a wide range of diseases in which the cerebral circulation is compromised. Tissue sections were stained by standard histochemical and immunocytochemical methods, the latter using antibodies to platelet membrane glycoprotein IIIa (CD61), and vascular endothelium (CD31). Results: In four of six cases of CNS SLE characterised by small vessel hyalinisation and thickening, fragments of platelet membrane were found in the walls of small cortical and meningeal vessels. Similar findings were not evident in two other SLE cases that were characterised by relatively short clinical histories and an acute vasculitis. One control case of severe polyarteritis nodosa showed platelet fragment deposition in arteries larger than the vessels so affected in SLE. Conclusions: Previous studies have suggested that neuropsychiatric symptoms in SLE may be related to repeated episodes of vasculitis in small cerebral vessels that are triggered by antiphospholipid antibodies. Concurrent thrombus formation might facilitate the incorporation ofplatelet fragments into small vessel walls. This process contributes to the thickening and irregularity of small vessels, a major feature of longstanding cases of CNS SLE.
Neuropsychiatric symptoms are common in systemic lupus erythematosus (SLE), occurring in up to 75% of cases.' 2 Central nervous system (CNS) pathology is found in about half the cases studied at necropsy, including some without CNS symptoms.3 The principal findings in two major reviews of the pathology of CNS SLE were vasculopathy and microinfarc- tion.45 The pathogenesis of these lesions is unclear, but antiphospholipid and antiendothelial antibodies present in the serum of some patients with SLE have been implicated in cerebrovascular damage.6 7 Transient inflammatory reactions involving such antibodies may, in combination with the action of antineuronal antibodies, underlie the fluctuating neuropsychiatric symptoms that occur during the course of SLE.89 The incorporation of platelet fragments from thrombi into vessel walls or the disruption of vascular endothelium might reasonably be expected during these inflammatory episodes, and may contribute to the cerebral vasculopathy in chronic cases. To investigate this possibility, we studied the vascular pathology in six cases of CNS SLE, using conventional histochemical methods and immunocytochemical methods with two antibodies. One of these detects platelet membranes (Y2/5 1: classified CD6 1), and the other labels vascular endothelium (JC70: classified CD3 1).
Methods
The clinical details of the six cases of CNS SLE that we examined are summarised in table 1. All six patients fulfilled the American Rheumatism Association's revised 1982 criteria for SLE.'°Fifteen control cases were selected for comparison. Three of these patients had normal brains, having died from myocardial infarction. The other cases were chosen because the cerebral vasculature had in some way been compromised. Two patients had had a single episode of cerebral infarction. Atherosclerosis and giant cell arteritis were the causes of multiple infarcts in two further cases. There were two patients who had polyarteritis nodosa with involvement of cerebral vessels. One of these had a particularly severe and widespread arteritis with fibrinoid necrosis. Five cases of CNS infection were included. Three were bacterial and two were fungal in origin. A reactive arteritis could be found in four of five of these cases; and small areas of infarction could be found in three of five cases. Fungal invasion of the vessels was seen in the example of Aspergillus meningitis.
Histological sections were cut from paraffin wax embedded, formalin fixed tissue. Routine histochemical methods (haematoxylin and eosin, cresyl violet and luxol fast blue, elastic van Gieson, Martius scarlet blue) were used. Immunocytochemistry was performed using the APAAP method as described previously."
The primary antibodies were: Y2/51 which recognises CD6 1, platelet membrane glycoprotein IlIa'2; and JC70 which recognises CD3 1, a membrane bound glycoprotein which occurs in vascular endothelium.'3 Adjacent tissue sections were used for immunocytochemistry because of the capacity of JC70 occasionally to label platelets.'3 A section to which serum, but not antibody, had been applied was included as a control. brains from patients with SLE was multifocal and ranged widely in size. Vascular abnormalities were evident in all six SLE patients. A vasculopathy that manifests as hyaline thickening, eosinophilia, and sometimes endothelial proliferation of small vessels was seen in four of six cases (table 2) . Deposits of material that were positively labelled by antibodyY2/51 (CD61) were found within the walls of a small proportion of thickened vessels in each of these cases (figs 2A and B) . The deposits were nearly always found in meningeal and cortical vessels with a diameter of less than 100 ,um, and up to 10 foci might be found in a typical section from the frontal pole. On adjacent sections from two of these four cases, JC70 (CD31) labelled material was very occasionally found at the same sites as the Y2/51 positive material (fig 3) . However, otherY2/5 1 deposits in these cases were not matched by JC70 staining on adjacent tissue sections; and the latter antibody elsewhere delineated normal endothelium alone. Intramural fibrin was rarely found in the thickened small vessels of the four cases with vasculopathy ( fig 4) .
No intramural Y2/51 deposits were seen in two of six cases of SLE. A feature of both these cases was acute vasculitis. In one, an acute inflammatory infiltrate of polymorph neutrophils disrupted small vessels and spread out into the surrounding necrotic tissue. was patchy and (case 3; tables 1 and 2) who had had the und macrophages, symptoms of CNS SLE for five months before utrophils; and a her death. These patients did not have a long og 5) history of CNS symptoms in contrast to the f Y2/5 1 or JC70 four with vasculopathy. Vasculopathy may be e in the non-SLE the hallmark of repeated attacks of CNS SLE few medium sized over several years, and the incorporation of ter) in the case Of platelet membranes into the walls of small fibrinoid necrosis vessels may be an epiphenomenon of the i 1 (fig 6) Antiphospholipid antibodies are als ciated with Libman-Sacks endocardi emboli from cardiac lesions may contr the cerebrovascular lesions.'7 Howevc the referenced pathological studies4 5 f( consistent association between cerebra and endocarditis. Libman-Sacks endc was found in only one of our cases tables 1 and 2). However, its abs4 necropsy in the other SLE patients d discount a 'similar process at some time their histories of CNS symptoms. In conclusion, we have shown the int deposition of platelet derived material cerebral vessels in four cases of CNS SI was not evident in two other cases i history of CNS SLE was relatively sh where thickening and eosinophilia c vessels were not found. Intramural deposition in association with vasct may follow repeated episodes of inflam A similar process may occur in slight] vessels in polyarteritis nodosa. The phenomenon appears rather specific because it was not seen in a variety of other inflammatory conditions that affect the cerebral vasculature. However, further study of more cases would be needed to confirm this.
